GLOBANT SA (NYSE:GLOB) Presents a Compelling Value Investment Case
GLOBANT SA (NYSE:GLOB) is presented as a compelling value investment opportunity, showing a strong valuation score of 8 out of 10 with a very inexpensive P/E ratio compared to its sector and the S&P 500. Despite a slowdown in recent sales growth, the company maintains a stable financial condition and consistent profitability, with moderate scores in financial health, earnings, and expansion. This combination of a low stock price and solid operational fundamentals suggests that GLOB is an underpriced security deserving of further research by value-focused investors.
Is Globant S.A. (GLOB) A Good Stock To Buy Now?
This article summarizes a bullish thesis on Globant S.A. (GLOB), a leading digital transformation and software engineering partner. The company is highlighted for its end-to-end services, strong positioning in AI and cloud solutions, and conservative financial sheet. Analysts expect continued double-digit revenue expansion, making GLOB a compelling long-term investment.
SG Americas Securities LLC Has $2.24 Million Stock Position in Globant S.A. $GLOB
SG Americas Securities LLC reduced its stake in Globant S.A. by 40.6% in Q4, holding 34,292 shares valued at approximately $2.24 million. Despite this, other major institutions like ARGA Investment Management and Invesco significantly increased their positions, contributing to institutional ownership of about 91.6% of the company's stock. Globant reported Q4 EPS of $1.54 and revenue of $612.5 million, with an average analyst rating of "Hold" and a target price of $80.80.
GLOB Should I Buy
An Intellectia AI analysis suggests that Globant SA (GLOB) is not a strong buy for long-term beginner investors, despite positive net income and EPS growth. The stock is currently rated as "Hold" due to analyst target reductions, a decline in revenue, and neutral technical indicators. While AI Pods offer potential long-term growth, near-term growth pressures and sector-wide challenges remain a concern.
Globant (NYSE:GLOB) Share Price Crosses Below 200-Day Moving Average - Should You Sell?
Globant (NYSE:GLOB) shares have fallen below their 200-day moving average, a bearish technical signal. The company's Q4 earnings met estimates, but revenue was down year-over-year, and analyst sentiment is cautious with a consensus "Hold" rating. Investors are advised to consider the mixed fundamentals and cautious analyst outlook.
Globant (NYSE:GLOB) Stock Price
Globant (NYSE:GLOB) stock is currently trading at US$47.85, significantly below its consensus fair value of US$73.36, indicating it is undervalued. Analysts have varying price targets, with a low of US$50 and a high of US$121.63, reflecting diverse outlooks on the company's future growth amidst AI-driven changes and IT services challenges. The company is actively integrating AI into its offerings and operations to drive higher-margin solutions and improve efficiency.
How Investors Are Reacting To Globant (GLOB) Expanding AI From Cancer Drug Discovery To Payments Infrastructure
Globant (GLOB) has announced collaborations with PharmaMar to use AI in cancer drug discovery and with Adyen for payments platform integration. These partnerships demonstrate Globant's strategy of embedding AI in critical workflows across different high-value industries. While the AI wins are significant, the article also notes investor caution regarding slower revenue growth, early-stage AI adoption, and potential client internalization of AI capabilities.
GLOB (Globant) Payments of Debt : $0 Mil (TTM As of Dec. 2025)
This article reports that Globant's (NYSE: GLOB) Payments of Debt was $0 Million as of December 2025, both for the trailing twelve months and the three months ending in December 2025. GuruFocus rates GLOB with a GF Score of 81/100 and considers it "Significantly Undervalued" with a GF Value of $209.37 compared to its current price of $44.52, despite listing six warning signs for investors to review. The article also provides historical data and competitive comparisons, noting that Payments of Debt is just one metric among several to consider for a complete financial analysis.
Globant (GLOB) price target decreased by 12.08% to 76.07
This article reports a significant 12.08% decrease in Globant's (GLOB) price target, bringing it down to $76.07. No specific reason or analyst is mentioned for this adjustment. Further details about the context or implications of this price target reduction are not provided in this brief snippet.
Globant (GLOB) price target decreased by 12.08% to 76.07
The article reports that the price target for Globant (GLOB) has been decreased by 12.08%, bringing it down to $76.07. No further details are provided in the snippet to explain the reason for this reduction.
Globant (GLOB) price target decreased by 12.08% to 76.07
Globant (GLOB) has seen its price target reduced by 12.08% to $76.07. This adjustment reflects a downward revision in analyst expectations for the company's valuation.
Globant schedules annual shareholder meeting for April 28 in Luxembourg By Investing.com
Globant S.A. (NYSE:GLOB) has announced its Annual General Meeting of Shareholders will be held on April 28, 2026, at its registered office in Luxembourg. The record date for voting shareholders is March 27, 2026, with the agenda and proxy form available in the meeting's convening notice. This information was released in a press statement and filed with the U.S. Securities and Exchange Commission.
Globant schedules annual shareholder meeting for April 28 in Luxembourg
Globant S.A. (NYSE:GLOB) has announced that its Annual General Meeting of Shareholders will take place on April 28, 2026, at its registered office in Luxembourg. The record date for determining eligible voters for the meeting was March 27, 2026. This information was released in a statement filed with the U.S. Securities and Exchange Commission, with the agenda and proxy form available in the convening notice.
Globant (NYSE: GLOB) sets AGM on 2025 results, loss allocation, board
Globant S.A. (NYSE: GLOB) has announced its Annual General Meeting (AGM) for April 28, 2026, with a record date of March 27, 2026. Shareholders will vote on 2025 financial results, including a consolidated gain of USD 103,956,201 and a Lux GAAP standalone loss of USD 9,582,792.49, which is proposed to be carried forward without dividend distribution. The agenda also includes approving compensation for non-executive directors, reappointing auditors PwC Luxembourg and Price Waterhouse & Co. S.R.L., and re-electing directors Linda Rottenberg, Martín Gonzalo Umaran, and Guibert Andrés Englebienne for terms ending in 2029.
Globant calls shareholders to Luxembourg meeting on April 28
Globant (NYSE: GLOB) has announced that its Annual General Meeting of Shareholders will take place on April 28, 2026, at its registered office in Luxembourg. The company has made the convening notice, agenda, proxy form, and other relevant meeting materials available on its investor relations website. This announcement follows a strong operational period for Globant, including robust Q4 2025 financial results and strategic AI-focused partnerships.
Globant to Hold its Annual General Meeting of Shareholders on April 28, 2026
Globant S.A. (NYSE: GLOB) announced that its Annual General Meeting of Shareholders will take place on April 28, 2026. The meeting will be held at the Company's registered office in Luxembourg, and relevant materials, including the agenda and proxy card, are available on Globant's investor website. Globant, a digitally native technology services company, specializes in creating digital journeys and leveraging AI for enterprise transformation.
Globant (NYSE:GLOB) Price Target Lowered to $50.00 at Wells Fargo & Company
Wells Fargo & Company has lowered its price target for Globant (NYSE:GLOB) to $50.00 from $57.00, maintaining an "equal weight" rating, which suggests a potential upside of 12.01%. This adjustment comes as several other analysts have also trimmed their price targets for the IT services provider. Despite this, Globant's stock has a consensus "Hold" rating and a target price of $80.80 among analysts.
Globant schedules annual shareholder meeting for April 28 in Luxembourg By Investing.com
Globant S.A. (NYSE:GLOB) has announced its Annual General Meeting of Shareholders will be held on April 28, 2026, at its registered office in Luxembourg. The record date for shareholders entitled to vote is March 27, 2026, with the agenda and proxy form available in the meeting's convening notice. This information was released in a statement filed with the U.S. Securities and Exchange Commission.
Is Globant’s New AI Deals in Payments and Cancer Research Altering The Investment Case For Globant (GLOB)?
Globant (GLOB) recently announced significant AI collaborations with Adyen, becoming its global lead integration partner for payments, and PharmaMar, deploying an AI system for cancer drug discovery. These deals demonstrate Globant's specialized AI capabilities in critical sectors, aiming to shift its investment narrative towards more recurring AI platform revenue despite current sluggish revenue guidance. However, investors should monitor execution and competition in AI services, as well as potential pressures on pricing and margins from automation.
Is Globant’s New AI Deals in Payments and Cancer Research Altering The Investment Case For Globant (GLOB)?
Globant recently announced two significant AI collaborations: becoming Adyen’s global lead integration partner for payments and teaming with PharmaMar for a multi-agent AI system to accelerate cancer drug discovery. These deals highlight Globant's embedding of its AI capabilities into critical infrastructure. While they support Globant's AI growth narrative, the immediate impact on soft top-line figures and pressured margins remains to be seen, with a focus on how specialized AI deployments can lead to higher-value, recurring revenue.
GLOB SEC Filings - Globant S A 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Globant S.A. (NYSE: GLOB) SEC filings, including annual reports (20-F), quarterly earnings (6-K), material events, and insider trading forms. It features AI-powered summaries of key documents, such as recent announcements of a share repurchase program, credit facility expansions, and beneficial ownership disclosures. The platform aims to centralize Globant's regulatory history to support in-depth analysis of its financial reporting and corporate actions.
Is It Time To Reconsider Globant (GLOB) After A 66% Share Price Slide?
Globant (GLOB) has experienced a significant 66% share price decline over the last year. Despite this, a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 54.4%, with an estimated intrinsic value of $98.09 per share against a current price of $44.71. Similarly, its current P/E ratio of 18.76x is below Simply Wall St's proprietary Fair Ratio of 30.26x, also indicating undervaluation.
Globant SA (NYSE:GLOB) Q4 2025 earnings call transcript
This document is the official Q4 2025 earnings call transcript for Globant SA (NYSE:GLOB). It contains the complete dialogue from the earnings call, providing insights into the company's financial performance and operational updates for the fourth quarter of 2025.
Globant SA (NYSE:GLOB) Q4 2025 earnings call transcript
This document is an earnings call transcript for Globant SA (NYSE:GLOB) for their Q4 2025 financial results. It contains the discussions and statements made during the call regarding the company's performance and future outlook.
Globant Taps AI Cancer Research And Payments Deals As Shares Lag Targets
Globant (NYSE:GLOB) has announced new collaborations, including an AI-focused partnership with PharmaMar for cancer drug discovery and an integration with payments platform Adyen for enterprise clients. These deals position Globant in the growing healthcare technology and digital commerce sectors. Despite these strategic moves, Globant's shares currently trade below analyst targets and an internal fair value estimate, with recent price pressure observed.
Globant initiated with a hold at Truist
Truist initiated coverage on Globant with a Hold rating. This indicates a neutral outlook on the stock's future performance by the firm.
Globant Taps AI Cancer Research And Payments Deals As Shares Lag Targets
Globant (NYSE:GLOB) has announced two significant collaborations: an AI-focused partnership with PharmaMar for cancer drug discovery and a global integration agreement with payment platform Adyen. These deals position Globant in the growing healthcare technology and fintech sectors. Despite these strategic moves, Globant's shares are trading significantly below analyst targets and an internal fair value estimate, with recent price pressure observed.
Globant Taps AI Cancer Research And Payments Deals As Shares Lag Targets
Globant announced collaborations with PharmaMar for AI-driven cancer drug discovery and with Adyen for global payments integration. These partnerships underscore Globant's strategic focus on healthcare technology and digital commerce through its core services. Despite these new deals, Globant's shares are trading significantly below analyst targets and an internal fair value estimate, with recent price momentum showing a decline.
Analysts Offer Insights on Technology Companies: Micron (MU), SanDisk Corp (SNDK) and Globant SA (GLOB)
The article provides insights from three analysts on technology companies Micron (MU), SanDisk Corp (SNDK), and Globant SA (GLOB), all expressing bullish sentiments. Vivek Arya of Bank of America Securities reiterated a Buy rating for Micron with a $500.00 price target, Asiya Merchant of Citi reiterated a Buy rating for SanDisk Corp with an $875.00 price target, and Mayank Tandon of Needham reiterated a Buy rating for Globant SA with a $60.00 price target. The article details analyst ratings, price targets, average returns, and success rates for each company.
Globant S.A. (NYSE:GLOB) Given Consensus Recommendation of "Hold" by Brokerages
Globant S.A. (NYSE:GLOB) has received a consensus "Hold" rating from brokerages, with an average 12-month target price of $81.27. Currently, 17 analysts cover the stock, comprising one sell, ten hold, and six buy recommendations. The company recently reported Q4 EPS matching expectations at $1.54 and revenue exceeding estimates at $612.5M, though revenue was down 4.7% year-over-year.
Globant (NYSE: GLOB) CRO details 74,108 shares and 58,406 RSUs
Globant S.A.'s Chief Revenue Officer, Fernando Matzkin, has reported his beneficial ownership of 74,108 shares of common stock and 58,406 Restricted Stock Units (RSUs). These RSUs vest over several dates through June 1, 2030, and some are conditioned on the company's common stock price reaching specific average minimums. The filing is an initial statement of beneficial ownership and does not reflect recent purchases or sales.
[Form 3] Globant S.A. Initial Statement of Beneficial Ownership
This Form 3 filing by Globant S.A. details the initial beneficial ownership of Englebienne Guibert Andres, President of Globant X & Ventures. He reports direct ownership of 268,602 common shares and indirect ownership of 127,166 shares through a revocable trust. The filing also outlines his restricted stock units, including 80,007 units vesting in tranches through 2030 and another 19,000 units with vesting conditioned on the company's stock price performance.
Globant (NYSE: GLOB) CFO details stock, option and RSU holdings
Globant S.A.'s Chief Financial Officer, Juan Ignacio Urthiague, filed an initial ownership report detailing his equity stake in the company. The report shows he directly owns 129,987 shares of common stock, along with options to purchase common stock expiring in 2028, and restricted stock units (RSUs). These RSUs have vesting schedules extending to 2030, with some performance-based awards vesting only if the average stock price reaches at least $350 by certain dates up to 2031.
Globant (GLOB) Partners with PharmaMar to Enhance Cancer Drug Discovery
Globant (GLOB) has partnered with PharmaMar to develop a multi-agent AI system for accelerated cancer drug discovery, achieving over 90% accuracy in data retrieval and significantly reducing research time. This collaboration aims to revolutionize the pharmaceutical industry by rapidly identifying promising drug candidates. Despite recent stock declines, Globant's valuation metrics suggest it is trading near historical lows, potentially offering opportunities for investors.
PharmaMar looks to accelerate oncology research with AI through collaboration with Globant
PharmaMar and Globant have partnered to accelerate cancer drug discovery using a multi-agent AI framework. This system achieves 15x faster insights with over 90% accuracy, analyzing vast amounts of data to identify high-potential drug candidates more quickly. The collaboration aims to revolutionize oncology research by enhancing decision-making and fostering digital innovation within PharmaMar's R&D ecosystem.
AI reviews 4,500 cancer documents to rank 10 treatment options
Globant and PharmaMar have partnered to launch a multi-agent AI framework to accelerate oncology research and development. This AI system can analyze over 4,500 documents and narrow down more than 8,000 possibilities to 10 high-potential treatment combinations, achieving insights 15 times faster with over 90% accuracy. The collaboration aims to revolutionize drug discovery by enhancing precision, scalability, and enabling faster decision-making for cancer treatments.
PharmaMar looks to accelerate oncology research with AI through collaboration with Globant
PharmaMar and Globant have partnered to accelerate cancer drug discovery using a new multi-agent AI framework. This system achieves 15 times faster insights with over 90% accuracy, enabling scientists to identify high-potential drug candidates rapidly by analyzing vast amounts of scientific, regulatory, and clinical data. The collaboration aims to significantly reduce the time and effort traditionally required for drug development in oncology.
Globant Expands Adyen Partnership to Enhance Payment Ecosystems
Globant has announced an expanded strategic partnership with Adyen to help businesses accelerate payment integrations and expand global commerce capabilities. Globant will serve as a key integration partner, streamlining onboarding, modernizing payment systems, and supporting continuous platform enhancements through its Financial Services AI Studio. This collaboration aims to provide faster system integrations and quicker revenue generation, especially for industries like retail and financial services.
Globant S.A. $GLOB Holdings Decreased by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its stake in Globant S.A. (NYSE:GLOB) by 2.2% in the third quarter of 2025, holding 1,336,556 shares valued at $76.7 million. This comes as Globant reported mixed financial results, with quarterly EPS meeting estimates and revenue slightly exceeding expectations, but a 4.7% year-over-year revenue decline. Analysts have a consensus "Hold" rating on the stock, with an average target price of $81.27, following recent price target cuts.
Linda Rottenberg discloses Globant (GLOB) stock and RSU holdings
Globant S.A. director Linda Rottenberg has filed an initial Form 3, disclosing her beneficial ownership of 9,799 shares of the company's common stock, including 4,666 restricted stock units (RSUs). These RSUs will convert into shares as they vest in several tranches between June 2026 and March 2027. This filing is a statement of holdings and does not indicate any recent purchase or sale transactions.
Globant (NYSE: GLOB) director lists 19,738 common shares and RSUs
Globant S.A. director Francisco Alvarez-Demalde has filed an initial ownership report, Form 3, disclosing beneficial ownership of 19,738 shares of the company's common stock. This filing includes 2,333 restricted stock units (RSUs) which will convert to common shares and vest in installments between June 2026 and March 2027. The report clarifies existing holdings and does not indicate any new buy or sell transactions.
Walt Disney’s Bengaluru centre triggers revenue risk for IT vendor Globant
Walt Disney's new global capability centre (GCC) in Bengaluru poses a significant revenue risk for its IT vendor Globant, which counts Disney as its largest client, contributing 9% of its 2025 revenue. This move highlights a broader trend where large companies are insourcing technology work, impacting IT service providers. The shift could adversely affect Globant's revenues and operations, particularly given its slowed growth in 2025 and reliance on the media and entertainment sector.
Globant (NYSE: GLOB) CTO details 78,320 shares and performance RSU awards
Globant's Chief Technology Officer, Diego Tartara, has disclosed an initial beneficial ownership of 78,320 common shares, including 61,763 time-based Restricted Stock Units (RSUs) vesting between June 2026 and June 2030. Additionally, Tartara holds 10,000 performance-based RSUs that will convert to common stock if the company's average stock price meets specific targets, starting at $350 by June 29, 2026, and increasing by $35 annually. The Form 3 filing serves as an initial ownership statement and does not indicate any recent buying or selling activity.
Globant (NYSE: GLOB) director discloses 4,175 shares and 2,333 RSUs
Globant S.A. director Petroni Merhy Andrea Mayumi has filed an initial ownership report, disclosing direct holdings of 4,175 shares of common stock. This total includes 2,333 restricted stock units (RSUs), which convert into one share each and are scheduled to vest through March 1, 2027. The filing indicates direct ownership for all reported securities.
Globant (NYSE: GLOB) officer discloses direct, trust and derivative equity stakes
Globant S.A.'s Chief Corporate Development Officer, Umaran Martin Gonzalo, has filed an initial ownership report detailing his equity stakes in the company. His holdings include direct shares, restricted stock units (RSUs), and shares held in a revocable trust. He also possesses derivative awards such as stock options and performance-based RSUs, with varying vesting schedules and conditions.
Globant and Adyen Establish Global Strategic Partnership for Payment Platform Integration
Globant and Adyen have announced a global strategic partnership, making Globant a lead integration partner for Adyen's payments platform. This collaboration aims to accelerate merchant onboarding, streamline payment system integrations, and support continuous innovation for clients worldwide. The partnership will primarily operate through Globant's Financial Services AI Studio, focusing on sectors like retail, financial services, media, entertainment, sports, and hospitality.
New Globant–Adyen deal aims to get merchants paid faster worldwide
Globant (NYSE: GLOB) and Adyen announced a global strategic partnership on March 18, 2026, formalizing Globant's role as a lead integration partner for Adyen's payments platform. This collaboration aims to accelerate merchant onboarding, shorten time to revenue, and streamline global payment expansion, particularly benefiting industries like retail, financial services, media, and hospitality. The partnership will leverage Globant's Financial Services AI Studio to provide scalable, AI-enabled payments integrations and continuous product upgrades for clients.
Globant and Adyen Establish Global Partnership to Accelerate Merchant Payment Integrations and Time to Revenue
Globant and Adyen have announced a global strategic partnership, formalizing Globant's role as a key integration partner for Adyen's payments platform. This collaboration aims to accelerate merchant onboarding, streamline payment system integrations, and support continuous innovation, especially benefiting sectors like retail and financial services. The partnership leverages Globant's digital transformation expertise with Adyen's robust global payments platform to help businesses modernize their payment infrastructure and expand globally.
Bank of Nova Scotia Acquires 374,500 Shares of Globant S.A. $GLOB
Bank of Nova Scotia significantly increased its stake in Globant S.A. (NYSE:GLOB) by purchasing 374,500 additional shares, bringing its total holding to 378,400 shares, valued at approximately $21.7 million. Despite recent revenue decline and price target cuts from analysts, Globant's institutional ownership remains high at 91.6%. The company reported earnings per share that matched estimates and revenue that beat expectations, with future guidance also provided.
Aquatic Capital Management LLC Boosts Stock Position in Globant S.A. $GLOB
Aquatic Capital Management LLC significantly increased its stake in Globant S.A. (NYSE:GLOB) by 271.2% in the third quarter, now owning 90,556 shares valued at $5.19 million. Other institutional investors like Goldman Sachs and Allworth Financial also adjusted their holdings. The article details Globant's financial performance, stock metrics, and recent analyst ratings, noting an average "Hold" rating and an average price target of $81.27.
